Related Experiment Video

Updated: Mar 15, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K

CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients

Nicholas Schwab1, Tilman Schneider-Hohendorf1, Heinz Wiendl1

  • 1Münster, Germany.

Neurology
|August 31, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.8K
Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

2.4K

Related Concept Videos